This topic contains a solution. Click here to go to the answer

Author Question: In a within-subjects design, who receives all levels of the independent variable? a. every ... (Read 134 times)

shenderson6

  • Hero Member
  • *****
  • Posts: 573
In a within-subjects design, who receives all levels of the independent variable?
 
  a. every participant
  b. those participants randomly assigned to groups
  c. only those assigned to the control group
  d. only those assigned to the experimental group

Question 2

The design below best illustrates which of the following designs? R Group 1 Level 1 M R Group 2 Level 2 M
 
  a. between-subjects design
  b. repeated measures design
  c. quasi-experimental design
  d. within-subjects design



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vboyd24

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

A

Answer to Question 2

A




shenderson6

  • Member
  • Posts: 573
Reply 2 on: Jun 20, 2018
Great answer, keep it coming :)


scikid

  • Member
  • Posts: 300
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library